"
Team:The Agency Escondido/safety
From 2013hs.igem.org
(Difference between revisions)
| Line 282: | Line 282: | ||
</ol> | </ol> | ||
| + | <p> Our project does not raise any safety concerns but transgenic organisms with antibiotics resistance should never leave the lab. | ||
<h2>Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? </h2> | <h2>Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? </h2> | ||
| Line 294: | Line 295: | ||
</ol> | </ol> | ||
| - | + | <p> As this is our primary year of even owning a biolab we decided to deal with parts already in Biobricks. | |
<h2> Is there a local biosafety group, committee, or review board at your institution? </h2> | <h2> Is there a local biosafety group, committee, or review board at your institution? </h2> | ||
| Line 300: | Line 301: | ||
<p> If no, which specific biosafety rules or guidelines do you have to consider in your country?</p> | <p> If no, which specific biosafety rules or guidelines do you have to consider in your country?</p> | ||
| - | + | <p> | |
<h2>Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?</h2> | <h2>Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?</h2> | ||
Revision as of 22:00, 4 June 2013
